Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience

Conti Andrea; Galdo Giovanna; Greco Maurizio; Borsari Stefania; Lasagni Claudia

首页> 外文期刊>Clinical drug investigation >Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience

【24h】

Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience

机译：Etanercept对中度至重度牛皮癣患者的长期安全性和有效性：5年数据经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical drug investigation》 |2013年第2期|共3页
作者
Conti Andrea; Galdo Giovanna; Greco Maurizio; Borsari Stefania; Lasagni Claudia;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience [J] . Conti Andrea, Galdo Giovanna, Greco Maurizio, Clinical drug investigation . 2013,第Suppla2期

机译：Etanercept对中度至重度牛皮癣患者的长期安全性和有效性：5年数据经验
2. The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis [J] . Griffiths C. E. M., Thaci D., Gerdes S., British Journal of Dermatology . 2017,第4期

机译：Egality研究：验证，随机，双盲研究比较GP2015的疗效，安全性和免疫原性，提出的依赖替替尼替康BioSimilar，与中度至严重的慢性牙菌斑型牛皮癣患者的发起者产品
3. Efficacy and safety of continuous versus paused etanercept treatment in patients with moderate-to-severe psoriasis over 54 weeks: the CRYSTEL study [J] . Jean-Paul Ortonne† Christopher EM Griffiths Esteban Daudén Robert Strohal Deborah Robertson Ronald Pedersen Charles Molta and Bruce Freundlich Expert Review of Dermatology . 2008,第6期

机译：CRYSTEL研究显示，持续或暂停依那西普治疗相对于中度至重度牛皮癣患者在54周内的疗效和安全性：
4. IMMEDIATE AND LONG-TERM EFFICACY AND SAFETY OF PHOTODYNAMIC THERAPY WITH PHOTOLON? (FOTOLON?) - A SEVEN-YEAR CLINICAL EXPERIENCE [C] . Yuri P. Istomin, Michael A. Kaplan, Siarhei. V. Shliakhtsin, World congress of the International Photodynamic Association . 2009

机译：使用光子进行光动力疗法的近期和长期疗效以及安全性？（FOTOLON？）-七年临床经验
5. Joint modeling time-to-event and longitudinal data using Markov chain Monte Carlo methods with application to the Proscar(TM) long-term efficacy and safety study. [D] . He, Weili. 2002

机译：使用Markov链蒙特卡罗方法对事件时间和纵向数据进行联合建模，并将其应用于Proscar（TM）的长期疗效和安全性研究。
6. Switch from reference etanercept to SDZ ETN an etanercept biosimilar does not impact efficacy safety and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III randomized double-blind EQUIRA study [O] . Janusz Jaworski, Marco Matucci-Cerinic, Hendrik Schulze-Koops, 2019

机译：从参考依那西普转向依那西普生物仿制药SDZ ETN不会影响依那西普在中度至重度类风湿关节炎患者中的功效安全性和免疫原性：III期随机双盲EQUIRA研究的48周结果
7. Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study [O] . Kristian Reich, Mark Goodfield, Lawrence Green, 2017

机译：4.持续对404周的104周的安全性和疗效，中度至严重的牛皮癣患者，持续对食物持续或从释放研究中的乙酸盐治疗转换

Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience

著录项

相似文献

相关主题

期刊订阅